The impact of polymeric excipients on the particle size of poorly soluble drugs after pH-induced precipitation
Language English Country Netherlands Media print-electronic
Document type Journal Article
PubMed
27539142
DOI
10.1016/j.ejps.2016.08.028
PII: S0928-0987(16)30318-9
Knihovny.cz E-resources
- Keywords
- Aggregation, Crystal growth, Dissolution, Dynamic light scattering, Particle size distribution, Precipitation,
- MeSH
- Chemical Precipitation * drug effects MeSH
- Dabigatran chemistry pharmacokinetics MeSH
- Hydrogen-Ion Concentration MeSH
- Polymers chemistry pharmacokinetics MeSH
- Excipients chemistry pharmacokinetics MeSH
- Povidone chemistry pharmacokinetics MeSH
- Rilpivirine chemistry pharmacokinetics MeSH
- Solubility drug effects MeSH
- Particle Size MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Dabigatran MeSH
- Polymers MeSH
- Excipients MeSH
- Povidone MeSH
- Rilpivirine MeSH
Active pharmaceutical ingredients (APIs) with strongly pH-dependent aqueous solubility can face the problem of precipitating from solution when the pH changes from acidic in the stomach to neutral in the intestine. The present work investigates the effect of two polymeric excipients - polyvinylpyrrolidone (PVP) and Soluplus - on the ability to either prevent precipitation, or to control the size distribution of precipitated particles when precipitation cannot be prevented. Two different APIs were compared, Dabigatran etexilate mesylate and Rilpivirine hydrochloride. The effect of excipient concentration on the precipitation behaviour during pH titration was systematically investigated and qualitatively different trends were observed: in case of Soluplus, which forms a micellar solution when critical micelle concentration is exceeded, precipitation was inhibited in the case of Dabigatran etexilate, which partitioned into the micelles. On the other hand, Rilpivirine precipitated independently of Soluplus concentration. In the case of PVP, which does not form micelles, precipitation could not be avoided. Increased polymer concentration, however prevented the aggregation of precipitated particles into larger cluster. The observed effect of PVP was especially pronounced for Rilpivirine. The main conclusion of this study is that a suitably chosen polymeric excipient can either prevent precipitation altogether or reduce the size of the resulting particles. The mechanism of action, however, seems-specific to a given molecule. It was also shown that the polymer-stabilised particles have a potential to redissolve.
References provided by Crossref.org